The amendment is purely technical and does not alter deal terms. Monitor for shareholder vote and S-4 filing for proxy/prospectus details. The activist 13D/A adds a layer of scrutiny but no immediate catalyst.
Price Chart
Executive Summary
Chemomab filed a 6-K reporting a technical amendment to its Domestication Merger Agreement with Scipher Medicine. The amendment introduces a formula-based exchange ratio to fix the Combined Company's post-merger share count at 10,000,000 shares, but does not change the economic consideration or ownership split. The merger remains on track for Q4 2026, with the combined entity expected to trade as 'SCIP'.
Key Facts
- Amendment No. 1 to Domestication Merger Agreement signed September 23, 2026.
- Introduces a formula-based Domestication Exchange Ratio to fix Combined Company shares at 10,000,000 post-closing.
- No change to economic consideration, ownership allocation, or merger timeline (Q4 2026).
- Combined Company expected to list on Nasdaq as 'SCIP' with Reginald Seeto as CEO.
- CVRs to be issued to Chemomab shareholders and vested option holders per the Merger Agreement.
- Activist HBM Healthcare Investments (Cayman) Ltd. filed a 13D/A 21 days prior, indicating activist stake context.
Financial Impact
Technical amendment only; no change to deal economics. Combined Company post-merger share count fixed at 10,000,000 shares.
Risk Factors
- Merger may fail to close if shareholder approval or regulatory conditions are not met.
- Post-merger share count fixed at 10M could imply significant dilution for current Chemomab holders depending on allocation percentage.
- Activist presence (HBM) may push for changes or oppose the deal.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-004676 |
| Exhibit: exhibit_2-1.htm | 0001178913-26-004676 |
| Document: 0001178913-26-004676-index-headers.html | 0001178913-26-004676 |
| Document: 0001178913-26-004676-index.html | 0001178913-26-004676 |
| Document: 0001178913-26-004676.txt | 0001178913-26-004676 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | 6-K | $1.18 $1.15 | ▼ −2.54% | ▼ −3.07% | $0.9729 (−17.55%) |
Sep 30, 2026 25d ago | 6-K | $1.30 $1.43 | ▲ +10.00% | ▲ +9.26% | $0.9729 (−25.16%) |
Aug 19, 2026 9w ago | 6-K | $2.09 $2.07 | ▼ −0.96% | ▼ −0.12% | $0.9729 (−53.45%) |
Aug 19, 2026 9w ago | Press Release | $2.09 $2.07 | ▲ +0.96% | ▲ +0.12% | $0.9729 (+53.45%) |
Jul 8, 2026 15w ago | 6-K | $1.97 $1.83 | ▼ −7.11% | ▼ −7.95% | $0.9729 (−50.61%) |
Jun 2, 2026 20w ago | 6-K | $1.72 $1.80 | ▲ +4.65% | ▲ +4.25% | $0.9729 (−43.44%) |
May 14, 2026 23w ago | 6-K | $1.70 $1.66 | ▼ −2.35% | ▼ −1.13% | $0.9729 (−42.77%) |
May 14, 2026 23w ago | Press Release | $1.70 $1.66 | ▼ −2.35% | ▼ −1.13% | $0.9729 (−42.77%) |
May 6, 2026 24w ago | 6-K | $1.74 $1.77 | ▲ +1.72% | ▲ +0.89% | $0.9729 (−44.09%) |
Mar 19, 2026 31w ago | Press Release | $1.93 $1.78 | ▼ −7.77% | ▼ −6.03% | $0.9729 (−49.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers